TITLE

The Case for Prevention

AUTHOR(S)
COLE, BEN
PUB. DATE
January 2009
SOURCE
HealthLeaders Magazine;Jan2009, Vol. 12 Issue 1, p14
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article focuses on the Heart of New Ulm program of Allina Hospitals and Clinics of Minneapolis, Minnesota. The program, which is a part of the hospital's Center for Healthcare Innovation, targets public awareness and education that covers early intervention and prevention of heart attacks. Program director Jeffrey VanWormer admits the challenges to changing the behavior of a community toward healthcare but believes in the proactive approach to providing healthcare services.
ACCESSION #
36828950

 

Related Articles

  • Analysis of cost-effectiveness of antidyslipidemic therapy for preventing myocardial infarction... Haynes, R. Brian // Cortlandt Forum;07/25/97, Vol. 10 Issue 7, p22 

    Discusses the use of antidyslipidemic therapy for the prevention of myocardial infarction (MI) and death in the United States. Debate over the effects of lowering elevated lipids; Individual baseline risk; Risk of subsequent cardiovascular events after MI.

  • Lifestyle changes reduce cardiovascular risk. Ryan, Patricia // Research Review (International Council on Active Aging);Apr2012, Vol. 12 Issue 13, p4 

    The article discusses the results of Heart of New Ulm Project, aimed at reducing heart attacks and coronary heart disease in New Ulm, Minnesota, that found reductions in factors including smoking, stress levels and hypertension, as well as in hyperlipidemia, and fasting glucose.

  • Modular prevention of heart disease following acute coronary syndrome (ACS) [ISRCTN42984084]. Redfern, Julie; Ellis, Elizabeth; Briffa, Tom; Freedman, SB // BMC Cardiovascular Disorders;2006, Vol. 6, p26 

    Background: Coronary heart disease (CHD) is a major cause of morbidity and mortality in Australia and it is recommended that all persons with unstable angina (UA) or myocardial infarction (MI) participate in secondary prevention as offered in cardiac rehabilitation (CR) programs. However, the...

  • Cardiovascular disease: microRNA protects the heart. Kingwell, Katie // Nature Reviews Drug Discovery;Feb2011, Vol. 10 Issue 2, p98 

    The article discusses research concerning the reduction of myocardial infarction's effects through microRNA (miRNA) miR-499. It references the study "mIr-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1," by J.-X. Wang and colleagues in the 2011 issue...

  • The new big O.  // India Today;1/31/2011, p43 

    The article reports on the finding that blood group O protects against heart attacks, according to a study in the medical journal "The Lancet."

  • Monday morning MIs. Donaldson Jr., Robert M.; Berkowitz, Henry D. // Cortlandt Forum;7/25/95, Vol. 8 Issue 7, p77 

    Discusses the preventive effects of aspirin on myocardial infarction. Avoiding weekend absence of aspirin; Time span of antiplatelet effects of a dose of aspirin.

  • Fish consumption reduces the risk of heart disease. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;01/25/98, Vol. 11 Issue 1, p14 

    Reveals study results suggesting that fish consumption reduces the risk of fatal myocardial infarctions. Result of a 1989 intervention trial indicating that eating two or three fish meals a week can reduce seven-year mortality.

  • Vitamin C and myocardial infarction: The heart of the matter. Padayatty, Sebastian J.; Levine, Mark // American Journal of Clinical Nutrition;May2000, Vol. 71 Issue 5, p1027 

    Editorial. Comments on studies associating vitamin C with reduced risk of myocardial infarction. Potency of vitamin C as a water-soluble oxidant; Improvement of vasodilation and vascular reactivity; Support of the role of vitamin C in heart disease.

  • ST-Elevation Myocardial Infarction: Preventive Percutaneous Coronary Intervention in the Non-Culprit Vessel. Triantafyllou, Konstantinos // Hospital Chronicles;2014, Vol. 9 Issue 3, p167 

    Patients with ST-segment elevation myocardial infarction (STEMI) and multi-vessel coronary disease (MVD) have poorer outcomes after primary percutaneous coronary intervention (PCI) compared to those with one-vessel disease. Current STEMI guidelines recommend revascularization of the infarct...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics